0 XP   0   0   0

Avidity Biosciences Inc
Buy, Hold or Sell?

I guess you are interested in Avidity Biosciences Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Avidity Biosciences Inc

Let's start. I'm going to help you getting a better view of Avidity Biosciences Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Avidity Biosciences Inc even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Avidity Biosciences Inc is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Avidity Biosciences Inc. The closing price on 2022-09-30 was $16.33 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Avidity Biosciences Inc Daily Candlestick Chart


Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of Avidity Biosciences Inc.

1.1. Profitability

An important factor of a company's health is the profitability.

1.1.1. Net Profit Margin

Measures how much net profit Avidity Biosciences Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Avidity Biosciences Inc to the Biotechnology industry mean.
  • A Net Profit Margin of -1,859.8% means that $-18.60 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Avidity Biosciences Inc:

  • The MRQ is -2,097.8%. The company is making a huge loss. -2
  • The TTM is -1,859.8%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-2,097.8%TTM-1,859.8%-238.0%
TTM-1,859.8%YOY-826.9%-1,032.9%
TTM-1,859.8%5Y-1,136.4%-723.4%
5Y-1,136.4%10Y-721.0%-415.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2,097.8%-242.4%-1,855.4%
TTM-1,859.8%-275.9%-1,583.9%
YOY-826.9%-342.1%-484.8%
5Y-1,136.4%-475.7%-660.7%
10Y-721.0%-561.7%-159.3%
1.1.2. Return on Assets

Shows how efficient Avidity Biosciences Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Avidity Biosciences Inc to the Biotechnology industry mean.
  • -8.7% Return on Assets means that Avidity Biosciences Inc generated $-0.09 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Avidity Biosciences Inc:

  • The MRQ is -10.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -8.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-10.9%TTM-8.7%-2.1%
TTM-8.7%YOY-6.2%-2.5%
TTM-8.7%5Y-6.9%-1.9%
5Y-6.9%10Y-4.0%-2.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-10.9%-9.7%-1.2%
TTM-8.7%-8.7%0.0%
YOY-6.2%-9.2%+3.0%
5Y-6.9%-11.5%+4.6%
10Y-4.0%-12.4%+8.4%
1.1.3. Return on Equity

Shows how efficient Avidity Biosciences Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Avidity Biosciences Inc to the Biotechnology industry mean.
  • -12.2% Return on Equity means the company generated $-0.12 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Avidity Biosciences Inc:

  • The MRQ is -12.2%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -9.7%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-12.2%TTM-9.7%-2.5%
TTM-9.7%YOY-6.8%-2.9%
TTM-9.7%5Y-7.1%-2.6%
5Y-7.1%10Y-4.1%-3.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-12.2%-11.8%-0.4%
TTM-9.7%-11.1%+1.4%
YOY-6.8%-10.6%+3.8%
5Y-7.1%-13.5%+6.4%
10Y-4.1%-14.5%+10.4%

1.2. Operating Efficiency of Avidity Biosciences Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Avidity Biosciences Inc is operating .

  • Measures how much profit Avidity Biosciences Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Avidity Biosciences Inc to the Biotechnology industry mean.
  • An Operating Margin of -2,125.8% means the company generated $-21.26  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Avidity Biosciences Inc:

  • The MRQ is -2,125.8%. The company is operating very inefficient. -2
  • The TTM is -1,863.3%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-2,125.8%TTM-1,863.3%-262.4%
TTM-1,863.3%YOY-827.3%-1,036.0%
TTM-1,863.3%5Y-1,060.8%-802.6%
5Y-1,060.8%10Y-675.0%-385.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2,125.8%-232.1%-1,893.7%
TTM-1,863.3%-269.6%-1,593.7%
YOY-827.3%-309.3%-518.0%
5Y-1,060.8%-466.7%-594.1%
10Y-675.0%-572.5%-102.5%
1.2.2. Operating Ratio

Measures how efficient Avidity Biosciences Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 2,225.8% means that the operating costs are $22.26for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Avidity Biosciences Inc:

  • The MRQ is 22.258. The company is inefficient in keeping operating costs low. -1
  • The TTM is 19.701. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ22.258TTM19.701+2.556
TTM19.701YOY9.278+10.424
TTM19.7015Y11.557+8.144
5Y11.55710Y10.928+0.629
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ22.2583.321+18.937
TTM19.7013.542+16.159
YOY9.2783.491+5.787
5Y11.5575.744+5.813
10Y10.9287.007+3.921

1.3. Liquidity of Avidity Biosciences Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Avidity Biosciences Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 1,200.0% means the company has $12.00 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Avidity Biosciences Inc:

  • The MRQ is 12.000. The company is very able to pay all its short-term debts. +2
  • The TTM is 14.444. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ12.000TTM14.444-2.444
TTM14.444YOY20.826-6.381
TTM14.4445Y13.488+0.956
5Y13.48810Y8.583+4.905
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ12.0005.266+6.734
TTM14.4446.060+8.384
YOY20.8266.366+14.460
5Y13.4886.692+6.796
10Y8.5836.457+2.126
1.3.2. Quick Ratio

Measures if Avidity Biosciences Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy (always compare to Biotechnology industry mean)
  • A Quick Ratio of 814.0% means the company can pay off $8.14 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Avidity Biosciences Inc:

  • The MRQ is 8.140. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 16.130. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ8.140TTM16.130-7.990
TTM16.130YOY20.844-4.714
TTM16.1305Y11.123+5.007
5Y11.12310Y7.078+4.045
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ8.1404.055+4.085
TTM16.1304.865+11.265
YOY20.8445.192+15.652
5Y11.1235.275+5.848
10Y7.0784.997+2.081

1.4. Solvency of Avidity Biosciences Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Avidity Biosciences Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy (always compare to Biotechnology industry mean).
  • A Debt to Asset Ratio of 0.11 means that Avidity Biosciences Inc assets are financed with 11.0% credit (debt) and the remaining percentage (100% - 11.0%) is financed by its owners/shareholders.

Let's take a look of the Debt to Asset Ratio trends of Avidity Biosciences Inc:

  • The MRQ is 0.110. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.100. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.110TTM0.100+0.011
TTM0.100YOY0.085+0.015
TTM0.1005Y0.249-0.149
5Y0.24910Y0.313-0.063
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1100.271-0.161
TTM0.1000.269-0.169
YOY0.0850.296-0.211
5Y0.2490.361-0.112
10Y0.3130.399-0.086
1.4.2. Debt to Equity Ratio

Measures if Avidity Biosciences Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy (always compare to Biotechnology industry mean).
  • A Debt to Equity ratio of 12.4% means that company has $0.12 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Avidity Biosciences Inc:

  • The MRQ is 0.124. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.111. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.124TTM0.111+0.013
TTM0.111YOY0.093+0.019
TTM0.1115Y0.160-0.049
5Y0.16010Y0.577-0.417
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1240.310-0.186
TTM0.1110.311-0.200
YOY0.0930.310-0.217
5Y0.1600.382-0.222
10Y0.5770.438+0.139

2. Market Valuation of Avidity Biosciences Inc

2. Earnings
2.1. Price to Earnings Ratio

Measures how many years it takes to double your invested money in Avidity Biosciences Inc.

  • Above 15 is considered overpriced but is hard to determine (always use industry average).
  • A PE ratio of -3.73 means the investor is paying $-3.73 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Avidity Biosciences Inc:

  • The EOD is -4.192. Company is losing money. -2
  • The MRQ is -3.730. Company is losing money. -2
  • The TTM is -6.319. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-4.192MRQ-3.730-0.462
MRQ-3.730TTM-6.319+2.589
TTM-6.319YOY-10.210+3.892
TTM-6.3195Y-5.386-0.933
5Y-5.38610Y-3.428-1.959
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-4.192-2.115-2.077
MRQ-3.730-2.332-1.398
TTM-6.319-3.889-2.430
YOY-10.210-5.087-5.123
5Y-5.386-3.697-1.689
10Y-3.428-3.390-0.038
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Avidity Biosciences Inc.

  • Lower is better
  • A PEG ratio of 1 means the investor is paying a fair price for the stock

Let's take a look of the Price Earnings to Growth Ratio trends of Avidity Biosciences Inc:

  • The MRQ is -0.043. Very Bad. -2
  • The TTM is 0.065. Very good. +2
Trends
Current periodCompared to+/- 
MRQ-0.043TTM0.065-0.108
TTM0.065YOY-0.138+0.204
TTM0.0655Y-0.037+0.102
5Y-0.03710Y-0.0370.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.0430.003-0.046
TTM0.0650.019+0.046
YOY-0.1380.042-0.180
5Y-0.0370.020-0.057
10Y-0.0370.017-0.054

2. Books
2.3. Price to Book Ratio

Measures if the stock price of Avidity Biosciences Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 2.02 means the investor is paying $2.02 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Avidity Biosciences Inc:

  • The EOD is 2.272. Good. +1
  • The MRQ is 2.021. Good. +1
  • The TTM is 2.141. Good. +1
Trends
Current periodCompared to+/- 
EOD2.272MRQ2.021+0.250
MRQ2.021TTM2.141-0.119
TTM2.141YOY3.195-1.054
TTM2.1415Y1.577+0.564
5Y1.57710Y1.004+0.573
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD2.2721.843+0.429
MRQ2.0211.961+0.060
TTM2.1412.789-0.648
YOY3.1953.538-0.343
5Y1.5772.782-1.205
10Y1.0042.419-1.415

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Avidity Biosciences Inc.

3.1. Institutions holding Avidity Biosciences Inc

Institutions are holding 101.315% of the shares of Avidity Biosciences Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2022-03-31T. Rowe Price Associates, Inc.15.31940.014979855352536893.2811
2022-03-31RTW INVESTMENTS, LLC9.19871.833479500000
2022-03-31Aaron Wealth Advisors LLC7.64462.9857398490237691521746.9998
2022-03-31FMR Inc7.31080.00563810915343910.9107
2022-03-31EcoR1 Capital, LLC5.29381.5943275950500
2022-03-31Federated Hermes Inc4.74710.1033247450000
2022-03-31Vanguard Group Inc4.40920.001229836329479114.7133
2022-06-30COWEN AND COMPANY, LLC4.34353.177226415022641500
2022-03-31RA Capital Management, LLC4.15790.873521673911743775411.6405
2022-03-31Avidity Partners Management LP3.92310.7865204500023000012.6722
2022-03-31Cormorant Asset Management, LLC3.862.8534201211500
2022-03-31State Street Corporation3.14970.0015164186724446417.4942
2022-06-30venBio Select Advisor LLC2.49390.3733130000000
2022-03-31Wellington Management Company LLP2.17880.0036113574411202410.9428
2022-03-31Boxer Capital LLC2.15111.0645112132700
2022-03-31Alethea Capital Management, LLC1.707314.87028899574200.0472
2022-03-31Alkeon Capital Management, LLC1.6430.031785646600
2022-03-31Geode Capital Management, LLC1.4140.0017737096228553.1999
2022-03-31Great Point Partners LLC0.95922.231950000000
2022-03-315AM Venture Management, LLC0.74921.575839055500
Total 86.654334.382445170388  

3.2. Funds holding Avidity Biosciences Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2022-06-30T. Rowe Price New Horizons5.92390.19473087928-2495-0.0807
2022-06-30Fidelity Growth Compy Commingled Pl 32.83640.0447147852130820.2089
2022-07-31Vanguard Total Stock Mkt Idx Inv2.68620.0019140024700
2022-06-30Federated Hermes Kaufmann Small Cap Grow2.53230.3968132000000
2022-06-30Federated Hermes Kaufmann Small Cap A2.53230.3976132000000
2022-06-30Federated Hermes Kaufmann Growth2.15820.3216112500000
2022-06-30Federated Hermes Kaufmann R2.15820.3229112500000
2022-06-30Fidelity® Growth Company2.14930.03961120363-6690-0.5936
2022-07-29iShares Russell 2000 ETF2.02940.032210578869250.0875
2022-06-30T. Rowe Price Health Sciences1.99740.09751041202-117072-10.1075
2022-06-30T. Rowe Price Small-Cap Value1.95190.13791017480-23055-2.2157
2022-07-31SPDR® S&P Biotech ETF1.62490.1831846997-5928-0.695
2022-07-31Vanguard Extended Market Index Investor1.15380.0113601465132322.2494
2022-06-30T. Rowe Price Small-Cap Stock1.14880.102598831-2700-0.4489
2022-07-29iShares Russell 2000 Value ETF0.93140.064248552000
2022-06-30T. Rowe Price U.S. SC Value Eq Tr-Z0.77380.143240337434000.8501
2022-06-30T. Rowe Price New Horizons Tr-Z0.7450.1954388334134133.5776
2022-06-30Fidelity® Growth Company K60.67760.052535321636081.032
2022-07-29iShares Biotechnology ETF0.67530.0716352020-544-0.1543
2022-06-30T. Rowe Price US Small-Cap Core Equity0.60980.101931787100
Total 37.29592.912619441255  

3.3. Insider Transactions

Insiders are holding 6.898% of the shares of Avidity Biosciences Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2022-08-15Sarah BoyceSELL10022.47
2022-08-15Sarah BoyceSELL10022.47
2022-08-15Sarah BoyceSELL10022.47
2022-08-15Sarah BoyceSELL10022.47
2022-08-15Sarah BoyceSELL10022.47
2021-11-18Arthur A LevinSELL2500027.89
2021-11-18Arthur A LevinSELL2500027.89
2021-11-18Arthur A LevinSELL2500027.89
2021-11-18Arthur A LevinSELL2500027.89
2021-11-18Arthur A LevinSELL2500027.89
2021-11-18Arthur A LevinSELL2500027.89
2021-11-18Arthur A LevinSELL2500027.89
2021-11-18Arthur A LevinSELL2500027.89
2021-11-18Arthur A LevinSELL2500027.89
2021-11-18Arthur A LevinSELL2500027.89
2021-08-04Rtw Investments, LpBUY80000018
2021-08-04Rtw Investments, LpBUY80000018
2021-08-04Rtw Investments, LpBUY80000018
2021-08-04Rtw Investments, LpBUY80000018
2021-08-04Rtw Investments, LpBUY80000018

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Avidity Biosciences Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Per Share--7.18810.065-29%7.851-8%8.569-16%5.670+27%
Book Value Per Share Growth---0.5990.038-1692%-7.858+1211%0.422-242%0.423-242%
Current Ratio--12.00014.444-17%20.826-42%13.488-11%8.583+40%
Debt To Asset Ratio--0.1100.100+11%0.085+30%0.249-56%0.313-65%
Debt To Equity Ratio--0.1240.111+12%0.093+34%0.160-22%0.577-78%
Dividend Per Share----0%-0%-0%-0%
Eps---0.877-0.974+11%-0.519-41%-0.670-24%-0.446-49%
Eps Growth--87.54943.063+103%55.600+57%71.121+23%71.121+23%
Gains Per Share---0.5990.038-1692%-7.858+1211%0.422-242%0.423-242%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.682+47%
Net Profit Margin---20.978-18.598-11%-8.269-61%-11.364-46%-7.210-66%
Operating Margin---21.258-18.633-12%-8.273-61%-10.608-50%-6.750-68%
Operating Ratio--22.25819.701+13%9.278+140%11.557+93%10.928+104%
Pb Ratio2.272+11%2.0212.141-6%3.195-37%1.577+28%1.004+101%
Pe Ratio-4.192-12%-3.730-6.319+69%-10.210+174%-5.386+44%-3.428-8%
Peg Ratio---0.0430.065-165%-0.138+224%-0.037-14%-0.037-14%
Price Per Share16.330+11%14.53020.350-29%25.048-42%14.989-3%9.539+52%
Quick Ratio--8.14016.130-50%20.844-61%11.123-27%7.078+15%
Return On Assets---0.109-0.087-20%-0.062-43%-0.069-37%-0.040-63%
Return On Equity---0.122-0.097-20%-0.068-44%-0.071-42%-0.041-67%
 EOD+1 -2MRQTTM+5 -13YOY+5 -135Y+5 -1310Y+9 -10

4.2. Fundamental Score

Let's check the fundamental score of Avidity Biosciences Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-4.192
Price to Book Ratio (EOD)Between0-12.272
Net Profit Margin (MRQ)Greater than0-20.978
Operating Margin (MRQ)Greater than0-21.258
Quick Ratio (MRQ)Greater than18.140
Current Ratio (MRQ)Greater than112.000
Debt to Asset Ratio (MRQ)Less than10.110
Debt to Equity Ratio (MRQ)Less than10.124
Return on Equity (MRQ)Greater than0.15-0.122
Return on Assets (MRQ)Greater than0.05-0.109
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Avidity Biosciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5035.672
Ma 20Greater thanMa 5019.790
Ma 50Greater thanMa 10019.651
Ma 100Greater thanMa 20017.018
OpenGreater thanClose16.900
Total3/5 (60.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2021-06-302021-09-302021-12-312022-03-312022-06-30
Other Stockholders Equity  381,213159,671540,88425,277566,16130,352596,513-599,499-2,986
Total Other Income Expense Net 14-8639216225-227-2



Latest Balance Sheet

Balance Sheet of 2022-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets420,801
Total Liabilities46,450
Total Stockholder Equity374,351
 As reported
Total Liabilities 46,450
Total Stockholder Equity+ 374,351
Total Assets = 420,801

Assets

Total Assets420,801
Total Current Assets404,251
Long-term Assets404,251
Total Current Assets
Cash And Cash Equivalents 125,106
Short-term Investments 273,112
Net Receivables 1,100
Total Current Assets  (as reported)404,251
Total Current Assets  (calculated)399,318
+/- 4,933
Long-term Assets
Property Plant Equipment 15,884
Other Assets 666
Long-term Assets  (as reported)16,550
Long-term Assets  (calculated)16,550
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities33,687
Long-term Liabilities12,763
Total Stockholder Equity374,351
Total Current Liabilities
Accounts payable 20,512
Other Current Liabilities 5,380
Total Current Liabilities  (as reported)33,687
Total Current Liabilities  (calculated)25,892
+/- 7,795
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt11,821
Long-term Liabilities  (as reported)12,763
Long-term Liabilities  (calculated)11,821
+/- 942
Total Stockholder Equity
Common Stock5
Other Stockholders Equity -2,986
Total Stockholder Equity (as reported)374,351
Total Stockholder Equity (calculated)-2,981
+/- 377,332
Other
Capital Stock5
Common Stock Shares Outstanding 52,081
Net Invested Capital 374,351
Net Tangible Assets 374,351
Net Working Capital 370,564



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312011-12-31
> Total Assets 
32,680
62,408
55,570
52,607
131,200
125,100
116,793
105,509
88,852
0
0
0
96,907
92,678
355,355
346,133
333,898
314,752
290,523
425,917
427,580
421,135
420,801
420,801421,135427,580425,917290,523314,752333,898346,133355,35592,67896,90700088,852105,509116,793125,100131,20052,60755,57062,40832,680
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
95,676
90,257
353,817
344,297
331,678
311,950
287,309
421,958
411,141
404,800
404,251
404,251404,800411,141421,958287,309311,950331,678344,297353,81790,25795,676000000000000
       Cash And Cash Equivalents 
24,315
53,717
46,285
40,015
117,367
113,307
106,666
95,100
78,273
0
0
0
94,578
88,751
352,446
341,142
321,462
301,273
276,423
410,013
320,448
139,262
125,106
125,106139,262320,448410,013276,423301,273321,462341,142352,44688,75194,57800078,27395,100106,666113,307117,36740,01546,28553,71724,315
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,679
6,641
3,035
3,016
85,095
257,809
273,112
273,112257,80985,0953,0163,0356,6416,6790000000000000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,200
1,200
1,400
900
900
900
1,100
1,1009009009001,4001,2001,2000000000000000000
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
1,231
2,421
1,538
1,836
2,220
2,802
3,214
3,959
16,439
16,335
16,550
16,55016,33516,4393,9593,2142,8022,2201,8361,5382,4211,231000000000000
       Property Plant Equipment 
4,046
3,192
3,086
2,966
3,113
3,000
2,749
2,775
2,480
0
0
0
631
1,051
1,254
1,295
1,468
2,187
2,556
3,220
15,589
15,286
15,884
15,88415,28615,5893,2202,5562,1871,4681,2951,2541,0516310002,4802,7752,7493,0003,1132,9663,0863,1924,046
       Intangible Assets 
1,173
1,146
1,075
1,023
991
1,044
975
1,418
1,447
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000001,4471,4189751,0449911,0231,0751,1461,173
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
600
1,863
767
541
752
615
658
739
850
1,049
666
6661,0498507396586157525417671,863600000000000000
> Total Liabilities 
29,268
41,872
39,956
42,584
40,591
38,003
19,021
18,320
21,299
0
0
0
162,264
26,676
25,059
25,969
27,675
28,636
26,043
31,040
46,150
45,427
46,450
46,45045,42746,15031,04026,04328,63627,67525,96925,05926,676162,26400021,29918,32019,02138,00340,59142,58439,95641,87229,268
   > Total Current Liabilities 
15,459
16,074
16,972
20,190
18,354
12,506
8,028
7,421
10,284
0
0
0
10,236
11,341
11,620
13,680
14,587
17,514
16,338
22,418
29,658
30,920
33,687
33,68730,92029,65822,41816,33817,51414,58713,68011,62011,34110,23600010,2847,4218,02812,50618,35420,19016,97216,07415,459
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
2,774
2,780
0
689
2,780
951
914
877
3,538
2,544
0
02,5443,5388779149512,78068902,7802,774000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
2,774
2,780
0
0
0
0
0
0
0
0
0
0000000002,7802,774000000000000
       Accounts payable 
3,278
3,151
3,597
5,348
3,531
2,632
3,027
2,044
4,033
0
0
0
0
3,172
5,399
6,028
7,745
10,212
8,499
18,157
14,085
18,421
20,512
20,51218,42114,08518,1578,49910,2127,7456,0285,3993,17200004,0332,0443,0272,6323,5315,3483,5973,1513,278
       Other Current Liabilities 
11,486
12,471
13,016
14,433
14,398
9,611
4,738
5,336
6,251
0
0
0
0
4,380
4,860
8,460
372
13,157
11,841
18,157
21,256
23,062
5,380
5,38023,06221,25618,15711,84113,1573728,4604,8604,38000006,2515,3364,7389,61114,39814,43313,01612,47111,486
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
152,028
15,335
13,439
12,289
13,088
11,122
9,705
8,622
16,492
14,507
12,763
12,76314,50716,4928,6229,70511,12213,08812,28913,43915,335152,028000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
1,098
0
0
0
0
0
0
0
0
0
0000000001,0980000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
-2,381
-2,483
679
0
-1,842
0
0
0
8,191
9,347
11,821
11,8219,3478,191000-1,8420679-2,483-2,381000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
45
45
0
0
0
0
0
0
0
0
0
0000000004545000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
1,300
0
0
0
0
0
0
0
0
0
0000000001,3000000000000000
> Total Stockholder Equity
3,412
20,536
15,614
10,023
90,609
87,097
97,772
87,189
67,553
0
0
0
-65,357
66,002
330,296
320,164
306,223
286,116
264,480
394,877
381,430
375,708
374,351
374,351375,708381,430394,877264,480286,116306,223320,164330,29666,002-65,35700067,55387,18997,77287,09790,60910,02315,61420,5363,412
   Common Stock
253
382
372
377
486
495
495
494
456
0
0
0
0
1
4
4
4
4
4
5
5
5
5
55554444410000456494495495486377372382253
   Retained Earnings Total Equity00000000000000000000000
   Accumulated Other Comprehensive Income 0-2,026-187-10-3-5-1,901-1,800-1,727-1,643000000000000
   Capital Surplus 000000000-42,6940000000000000
   Treasury Stock00000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
-42,694
0
372,326
372,764
376,499
381,213
540,884
566,161
596,513
-2,986
-2,986596,513566,161540,884381,213376,499372,764372,3260-42,6940000000000000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue9,326
Cost of Revenue--
Gross Profit-9,326
 
Operating Income (+$)
Gross Profit-
Operating Expense-127,377
Operating Income-118,051-127,377
 
Operating Expense (+$)
Research Development101,182
Selling General Administrative26,195
Selling And Marketing Expenses-
Operating Expense127,377127,377
 
Net Interest Income (+$)
Interest Income104
Interest Expense-0
Net Interest Income104104
 
Pretax Income (+$)
Operating Income-118,051
Net Interest Income104
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-118,009-118,093
EBIT - interestExpense = -118,009
-118,009
-118,009
Interest Expense0
Earnings Before Interest and Taxes (ebit)-118,009-118,009
Earnings Before Interest and Taxes (ebitda)-117,370
 
After tax Income (+$)
Income Before Tax-118,009
Tax Provision--
Net Income From Continuing Ops-118,009-118,009
Net Income-118,009
Net Income Applicable To Common Shares-118,009
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net42-104
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
VOLT.CC
5 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of VOLT.CC.

VOLT.CC Daily Candlestick Chart
VOLLAR.CC
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of VOLLAR.CC.

VOLLAR.CC Daily Candlestick Chart
VIB.CC
5 hours ago

I found you a RSI Bullish Hidden Divergence on the daily chart of VIB.CC.

VIB.CC Daily Candlestick Chart
TRIO.CC
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of TRIO.CC.

TRIO.CC Daily Candlestick Chart
TKX.CC
5 hours ago

I found you a Golden Cross on the daily chart of TKX.CC.

TKX.CC Daily Candlestick Chart
TERC.CC
5 hours ago

I found you a Three Black Crows Candle Pattern on the daily chart of TERC.CC.

TERC.CC Daily Candlestick Chart
RENTBERRY.CC
5 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of RENTBERRY.CC.

RENTBERRY.CC Daily Candlestick Chart
STOX.CC
5 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of STOX.CC.

STOX.CC Daily Candlestick Chart
STO.CC
5 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of STO.CC.

STO.CC Daily Candlestick Chart
STM.CC
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of STM.CC.

STM.CC Daily Candlestick Chart
SPORTS.CC
5 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SPORTS.CC.

SPORTS.CC Daily Candlestick Chart
SPIRIT.CC
5 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of SPIRIT.CC.

SPIRIT.CC Daily Candlestick Chart
SHIELD.CC
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SHIELD.CC.

SHIELD.CC Daily Candlestick Chart
SHB.CC
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SHB.CC.

SHB.CC Daily Candlestick Chart
SFM.CC
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SFM.CC.

SFM.CC Daily Candlestick Chart
QI.CC
6 hours ago

I found you a Bearish Three Line Strike Candle Pattern on the daily chart of QI.CC.

QI.CC Daily Candlestick Chart
PYRO.CC
6 hours ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of PYRO.CC.

PYRO.CC Daily Candlestick Chart
PTF.CC
6 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of PTF.CC.

PTF.CC Daily Candlestick Chart
PREMIA.CC
6 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of PREMIA.CC.

PREMIA.CC Daily Candlestick Chart
POX.CC
6 hours ago

I found you a Death Cross on the daily chart of POX.CC.

POX.CC Daily Candlestick Chart
PLURA.CC
6 hours ago

I found you a MACD Bearish Reversal Divergence on the daily chart of PLURA.CC.

PLURA.CC Daily Candlestick Chart
PLAY.CC
6 hours ago

I found you a MACD Bullish Hidden Divergence on the daily chart of PLAY.CC.

PLAY.CC Daily Candlestick Chart
PHR.CC
6 hours ago

I found you a Bearish Three Line Strike Candle Pattern on the daily chart of PHR.CC.

PHR.CC Daily Candlestick Chart
PAYT.CC
6 hours ago

I found you a MACD Bearish Hidden Divergence on the daily chart of PAYT.CC.

PAYT.CC Daily Candlestick Chart